DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 236 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2022. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
| Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
| Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
| Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
| Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
| RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
| Maven Securities LTD | 264,989 | $931,000 | 0.29% |
| Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
| GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |